Bracco and Avicenna.AI win FDA clearance for UPTUNITY Aneurysm, AI that flags brain aneurysms on CT
The 510(k)-cleared detection and diagnosis software reads cerebral CT angiography inside radiologists' existing workflow, for new findings and follow-up of known aneurysms; it is the first product in Bracco's new UPTUNITY interpretive AI portfolio.
Key facts
- FDA 510(k) clearance announced 13 November 2026
- Reads cerebral arteries CT angiography (CTA) images
- Computer-assisted detection (CADe) and diagnosis (CADx)
- First product in Bracco's UPTUNITY portfolio
- Bracco cites about one in 50 US adults having an unruptured brain aneurysm